Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moringa oleifera Nanoparticles vs Nystatin for Otomycosis
NCT04768829Phase 1Completed
- Sponsor
- Deraya University
- Start
- Feb 2021
- Primary completion
- Sep 2021
- Modality
- PE (Plant Extract), Dietary Supplement
- Countries
- 1
01
Overview
Phase 1, randomised trial in otomycosis comparing Moringa group with Placebo group (Nystatin) (2 arms). Primary endpoints: Number of participants recovered with clear endoscopic examination at 1 week and Identification of different microorganisms infected ear at 1 month. Started Feb 2021; status: completed.
02
Drugs
moringa oleifera
03
Conditions
otomycosis
Beyond the preview
Go deeper on NCT04768829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04768829.